Acadian Asset Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-8,868
| Closed | -$19K | – | 1686 |
|
2023
Q4 | $19K | Sell |
8,868
-8,742
| -50% | -$18.7K | ﹤0.01% | 1593 |
|
2023
Q3 | $50K | Buy |
+17,610
| New | +$50K | ﹤0.01% | 1431 |
|
2021
Q1 | – | Sell |
-566,314
| Closed | -$3.4M | – | 2191 |
|
2020
Q4 | $3.4M | Buy |
566,314
+179,630
| +46% | +$1.08M | 0.01% | 608 |
|
2020
Q3 | $2.87M | Sell |
386,684
-945,502
| -71% | -$7.02M | 0.01% | 572 |
|
2020
Q2 | $5.35M | Sell |
1,332,186
-208,550
| -14% | -$837K | 0.02% | 470 |
|
2020
Q1 | $3.91M | Sell |
1,540,736
-146,945
| -9% | -$373K | 0.02% | 443 |
|
2019
Q4 | $5.87M | Buy |
1,687,681
+417,327
| +33% | +$1.45M | 0.03% | 407 |
|
2019
Q3 | $5.88M | Buy |
1,270,354
+215,610
| +20% | +$998K | 0.03% | 439 |
|
2019
Q2 | $13M | Buy |
1,054,744
+208,982
| +25% | +$2.57M | 0.06% | 243 |
|
2019
Q1 | $11.2M | Buy |
845,762
+307,013
| +57% | +$4.08M | 0.05% | 278 |
|
2018
Q4 | $4.64M | Buy |
538,749
+62,686
| +13% | +$540K | 0.02% | 387 |
|
2018
Q3 | $3.57M | Buy |
476,063
+49,972
| +12% | +$374K | 0.01% | 439 |
|
2018
Q2 | $2.54M | Buy |
426,091
+124,708
| +41% | +$743K | 0.01% | 504 |
|
2018
Q1 | $1.76M | Buy |
301,383
+154,678
| +105% | +$904K | 0.01% | 613 |
|
2017
Q4 | $864K | Buy |
146,705
+59,839
| +69% | +$352K | ﹤0.01% | 715 |
|
2017
Q3 | $438K | Sell |
86,866
-94,521
| -52% | -$477K | ﹤0.01% | 805 |
|
2017
Q2 | $732K | Sell |
181,387
-120,318
| -40% | -$486K | ﹤0.01% | 756 |
|
2017
Q1 | $1.72M | Buy |
301,705
+95,056
| +46% | +$541K | 0.01% | 658 |
|
2016
Q4 | $1.5M | Sell |
206,649
-37,809
| -15% | -$275K | 0.01% | 643 |
|
2016
Q3 | $1.96M | Sell |
244,458
-21,532
| -8% | -$173K | 0.01% | 551 |
|
2016
Q2 | $2.4M | Sell |
265,990
-161,066
| -38% | -$1.45M | 0.01% | 491 |
|
2016
Q1 | $3.45M | Buy |
427,056
+337,583
| +377% | +$2.72M | 0.02% | 458 |
|
2015
Q4 | $968K | Buy |
+89,473
| New | +$968K | 0.01% | 696 |
|